Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2009 October;100(5): > Minerva Medica 2009 October;100(5):415-20

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,236


eTOC

 

  OVARIAN CANCER


Minerva Medica 2009 October;100(5):415-20

language: English

PET/CT scans in ovarian cancer: prognostic versus predictive utility?

Markman M.

Department of Gynecologic Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA


PDF  


The use of PET/CT has been advocated in the management of ovarian cancer as a diagnostic strategy to assist in patient management. To date, data in the peer reviewed literature support the argument that findings on PET/CT reveal evidence of the extent of disease and may be helpful in documenting disease recurrence. However, it remains to be determined through the conduct of phase 3 randomized trials if the information generated will be useful in predicting benefit of a management plan specifically selected based on the results of this expensive radiographic procedure.

top of page

Publication History

Cite this article as

Corresponding author e-mail

mmarkman@mdanderson.org